http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106094248-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-066
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02C5-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02C5-001
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02C5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06
filingDate 2016-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2019-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106094248-B
titleOfInvention A kind of spectacle frame containing negative oxygen ion and its processing technology
abstract The invention provides a spectacle frame containing negative oxygen ions and a processing technology thereof. The spectacle frame containing negative oxygen ions includes plastic titanium and negative oxygen ion powder; wherein, in terms of mass percentage, the content of the negative oxygen ion powder is 1% to 20%. The negative oxygen ion powder provided by the present invention comes from natural mines. Its composition is a mixture of various elements. The spectacle frame made of the negative oxygen ion powder contains far infrared rays with wavelengths of 6-14 μ and negative oxygen ions of 1100/cm 3 . The spectacle frame has a relatively significant adjuvant treatment effect on diseases outside the eye, and also has a relatively significant adjuvant treatment effect on diseases inside the eye. Especially for users with presbyopia and myopia, it has the effect of stabilizing and reducing the development of presbyopia and myopia; it can also effectively improve the microcirculation of tissues around the eyes, supplement negative oxygen ions to fight free radicals, Both external and intraocular diseases have a good preventive effect.
priorityDate 2016-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-203480150-U
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID409301
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23963
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559477
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID55634
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID372428
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID372428
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID55634
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585712

Total number of triples: 23.